Showing results (261-270 of 346) with videos related to

Sort By:
Pageof 35
American Journal of Obstetrics and Gynecology|July 20, 1999
Decreasing estrogen in nonpregnant women lowers uterine myometrial type I nitric oxide synthase protein expressionA D Weeks, A G Massmann, J M Monaghan, et al.
British Journal of Cancer|May 1, 1980
Relationship between the pretreatment proliferative activity of marrow blast cells and prognosis of acute lymphoblastic leukaemia of childhoodJ H Scarffe, I M Hann, D I Evans, et al.
British Journal of Cancer|October 1, 1994
Establishment of a murine leukaemia cell line resistant to the growth-inhibitory effect of bryostatin 1J Prendiville, A T McGown, A Gescher, et al.
British Journal of Cancer|February 1, 1989
Prognostic factors in high and intermediate grade non-Hodgkin's lymphomaR A Cowan, M Jones, M Harris, et al.
European Journal of Cancer & Clinical Oncology|September 1, 1988
Comparative toxicity of cisplatin, carboplatin (CBDCA) and iproplatin (CHIP) in combination with cyclophosphamide in patients with advanced epithelial ovarian cancerH Anderson, J Wagstaff, D Crowther, et al.
British Journal of Cancer|February 1, 1992
Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856)E S Newlands, G R Blackledge, J A Slack, et al.
The British Journal of Surgery|February 1, 1991
Cytoreductive surgery in disseminated non-seminomatous germ cell tumours of testisR P Kulkarni, K W Reynolds, E S Newlands, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1983
Blood clearance of radioactively labelled cis-diammine 1,1-cyclobutane dicarboxylate platinum (II) (CBDCA) in cancer patientsH Sharma, N Thatcher, J Baer, et al.
British Journal of Cancer|July 29, 1999
Further investigation of the role of HLA-DPB1 in adult Hodgkin's disease (HD) suggests an influence on susceptibility to different HD subtypesG M Taylor, D A Gokhale, D Crowther, et al.
British Journal of Cancer|April 15, 2010
A Phase Ib trial of CA4P (combretastatin A-4 phosphate), carboplatin, and paclitaxel in patients with advanced cancerG J Rustin, G Shreeves, P D Nathan, et al.
Pageof 35